Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study

INTRODUCTION: Mammographic density (MD) is a strong biomarker of breast cancer risk. MD increases after women start estrogen plus progestin therapy (EPT) and decreases after women quit EPT. A large interindividual variation in EPT-associated MD change has been observed, but few studies have investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eunjung, Luo, Jianning, Su, Yu-Chen, Lewinger, Juan Pablo, Schumacher, Fredrick R, Van Den Berg, David, Wu, Anna H, Bernstein, Leslie, Ursin, Giske
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318222/
https://www.ncbi.nlm.nih.gov/pubmed/25499601
http://dx.doi.org/10.1186/s13058-014-0477-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318222/
https://www.ncbi.nlm.nih.gov/pubmed/25499601
http://dx.doi.org/10.1186/s13058-014-0477-8

Ejemplares similares